Table 1. A chronologically-ordered literature review of reported cases of primary vaginal adenocarcinoma of intestinal-type.
CEA: Carcinoembryonic antigen, EMA: Epithelial membrane antigen, CK20: Cytokeratin 20, CK7: Cytokeratin 7, ER: Estrogen receptor, PR: Progesterone receptor, CDX2: Caudal-type homeobox 2, SATB2: Special AT-rich sequence-binding protein 2, TTF-1: Thyroid transcription factor 1, HPV: Human papillomavirus, MMR proteins: Mismatch repair proteins
| Authors | Patient Age (years) | Tumor Size (cm) | Tumor Site | Immunohistochemical & Other Stains | DES exposure |
| Fukushima et al. [14] (1986) | 32 years | 3 x 3 x 2 cm | Distal third of the vaginal wall | Neuroendocrine markers were expressed due to mixed components | Unknown |
| Fox et al. [6] (1988) | 35 years | 5 x 2 cm | Left lateral and anterior vaginal wall | Unknown | Unknown |
| Yaghsezian et al. [15] (1992) | 52 years | 1 cm | Posterior distal vaginal wall | Unknown | Not present |
| Nagar et al. [16] (1999) | 36 years | Depth only: 0.1 cm | Upper anterior vaginal wall | Not reported | Not present |
| Heller et al. case 1 [17] (2000) | 55 years | 7 x 4 cm | Anterior lower vaginal wall | CEA+, EMA+ | Not present |
| Heller et al. case 2 [17] (2000) | 52 years | 2.5 cm | Anterior lower vaginal wall | CEA+, EMA+ | Not present |
| Mudhar et al. [18] (2001) | 56 years | 1 cm | Distal posterior vaginal wall | CEA+, CK20+, CK7- | Not present |
| Tjalma and Colpaert et al. [19] (2006) | 55 years | 4.5 x 4 x 2.7 cm | Anterior lower and posterior vaginal walls | CEA+, CK20+, CK7+, ER-, PR- | Unknown |
| Ditto et al. [1] (2007) | 53 years | 1 x 2 cm | Distal posterior vaginal wall | CK20+, CDX2+, CK7- | Not present |
| Driss et al. [20] (2007) | 70 years | 4 cm | Anterior lower and middle vaginal walls | CEA+, CK20+, EMA+, CK7- | Not present |
| van Wessel et al. [21] (2013) | 68 years | 1 x 1.3 cm | Posterior wall of vaginal introitus | CEA+, CK20+, CK7+ | Not present |
| Staats et al. [22] 10 cases (2014) | Range: 36 to 86 years | Range: 0.8 to 1.5 cm | Variable | CEA+, CK20+, CDX2+, CK (+/-), ER-, PR- | Not present in most cases, few could not be excluded |
| Tatsumi et al. [3] (2015) | 64 years | 2 cm | Posterior vaginal wall | CK20+, CDX2+, CK7+ (focal), ER- | Present |
| Broggi et al. [23] (2018) | 51 years | 2 cm | Posterior wall of vaginal introitus | CEA+, CK20+, CDX2+, CK7+ (focal), ER-, PR- | Not reported |
| Ugwu et al. [9] (2019) | 40 years | 6 x 3 cm | Posterior wall of the lower-third of the vagina with extension to the introitus | Not reported | Not reported |
| Current case (2022) | 62 years | Bilobed components: 1.8 cm, and 2.3 cm | Bilobed components: Middle one-third of the vagina, and lower one-third of the vagina (respective to size) | CEA+, CK20+, CDX2+, EMA+ (focal), SATB2+, TTF-1+ (patchy) CK7-, ER-, PR-, p16-, GATA3- In-situ hybridization for high-risk HPV – MMR proteins - | Not present |